Common variable immunodeficiency (CVID) is a rare primary immunodeficiency disease characterized by hypogammaglobulinemia and recurrent bacterial infections especially in respiratory and gastrointestinal systems. The authors present here a case of CVID with uncommon gastrointestinal manifestation in the form of CVID enteropathy. Based upon the clinical presentation and histopatholic findings the patient was diagnosed as CVID enteropathy and treated with intravenous antibiotics and 3-4 wkly intravenous immunoglobulin infusion and he had responded poorly to gastrointestinal symptoms but the frequency of respiratory and skin infection reduced. CVID has heterogenous gastrointestinal manifestations; among them the CVID enteropathy is an uncommon presentation which responds poorly to the mainstay therapy of intravenous immunoglobulin infusion and represents a diagnostic as well as therapeutic challenge for treating physician.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12098-011-0635-2DOI Listing

Publication Analysis

Top Keywords

cvid enteropathy
12
intravenous immunoglobulin
8
immunoglobulin infusion
8
cvid
7
cvid enteropathy-
4
enteropathy- rare
4
rare chronic
4
chronic diarrhea
4
diarrhea child
4
child common
4

Similar Publications

: Gastrointestinal diseases are a major cause of morbidity in common variable immunodeficiency disorder (CVID), clinically often mimicking other conditions including celiac disease and inflammatory bowel disease (IBD). Hence, diagnosis of CVID remains challenging. This study aims to raise awareness and highlight histopathological clues for CVID in intestinal biopsies, emphasizing diagnostic pitfalls for the pathologist/gastroenterologist.

View Article and Find Full Text PDF

A patient with CVID-enteropathy successfully treated with ustekinumab.

Immunol Res

December 2024

Department of Immunology, North Bristol NHS Trust, Bristol, UK.

CVID (common variable immunodeficiency) is associated with a variety of gastrointestinal disorders including those mimicking Crohn's disease and ulcerative colitis. At present there is no clear trial data for the treatment of CVID enteropathy. There are no specific recommendations for treatment; however, it is commonly treated in a similar manner to inflammatory bowel disease, with corticosteroids, 5-aminosalicylates (5-ASA), azathioprine and anti-TNF therapy all being used.

View Article and Find Full Text PDF

Purpose Of Review: Common variable immunodeficiency enteropathy (CVID-E) is a noninfectious complication of CVID caused by chronic inflammation of the gastrointestinal (GI) tract. Based on literature, a paucity or lack of plasma cells, although not obligatory for diagnosis, is a pathognomonic feature of CVID and more frequent in CVID-E. However, there is no consensus on standardized histopathological analysis of this feature in biopsies.

View Article and Find Full Text PDF
Article Synopsis
  • Human noroviruses (HuNoVs) are key contributors to diarrhea outbreaks worldwide, and studying them was difficult due to a lack of effective culture methods.
  • Recent advancements in cultivating various HuNoV strains in human intestinal enteroids (HIEs) have greatly improved research into their replication and disease mechanisms.
  • The research showed that different types of HIEs, particularly those from small intestines and genetically modified lines, have varying levels of susceptibility to HuNoV infection, revealing insights into how these viruses affect human health.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!